Mr Jeremiah Smith, CSW | |
51 E 800 N, Spanish Fork, UT 84660-1210 | |
(962) 343-5314 | |
Not Available |
Full Name | Mr Jeremiah Smith |
---|---|
Gender | Male |
Speciality | Counselor - Mental Health |
Location | 51 E 800 N, Spanish Fork, Utah |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1457024093 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YM0800X | Counselor - Mental Health | 10118675-3502 (Utah) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Jeremiah Smith, CSW 1991 Laguna Vista Dr, Orem, UT 84058-7545 Ph: (435) 229-4690 | Mr Jeremiah Smith, CSW 51 E 800 N, Spanish Fork, UT 84660-1210 Ph: (962) 343-5314 |
News Archive
Can it be that the stress on the use of antiseptics and antibiotics in hospitals is actually putting patients at a greater risk of suffering fatal bacterial infection?
ImmunoCellular Therapeutics announced today that clinical data from its Phase I trial of ICT-107 was accepted for publication, and is currently in the online edition of the prestigious medical journal Cancer Immunology, Immunotherapy.
PTC Therapeutics, Inc. (PTC) today announced the pricing of its initial public offering of 8,372,000 shares of common stock at a public offering price of $15.00 per share, before underwriting discounts. All of the shares in the offering are being sold by PTC.
The company GB Sciences Inc. has obtained the exclusive global worldwide intellectual property license for this innovative solution, which is based on nanotechnology.
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
› Verified 5 days ago
Desmond Cornell Lomax, CMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 31 E 1600 N, Spanish Fork, UT 84660 Phone: 801-616-1764 | |
Mr. Lynn Loftin, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 31 E 1600 N, Spanish Fork, UT 84660 Phone: 801-361-9917 Fax: 801-798-8949 | |
Mr. Brian Mark Thomas, LCSW Counselor Medicare: Medicare Enrolled Practice Location: 1251 Firefly Dr, Spanish Fork, UT 84660 Phone: 801-589-9211 | |
Heather Boogert, Counselor Medicare: Not Enrolled in Medicare Practice Location: 350 S Main St, Spanish Fork, UT 84660 Phone: 801-354-7416 | |
Odell Erickson, Counselor Medicare: Not Enrolled in Medicare Practice Location: 31 E 1600 N, Spanish Fork, UT 84660 Phone: 801-798-9077 Fax: 801-798-8949 | |
Nancie Ann Silva-dahl, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1422 S Barley Dr, Spanish Fork, UT 84660 Phone: 435-720-2464 | |
Jeffrey Robison, Counselor Medicare: Not Enrolled in Medicare Practice Location: 350 S Main St, Spanish Fork, UT 84660 Phone: 801-354-7416 |